IBA Proton Therapy

IBA Proton Therapy is a global leader in particle therapy, specializing in proton therapy, a precise method for targeting cancer cells. Founded in 1986 as a spin-off from the University of Louvain in Belgium, IBA has grown to employ over 1,300 people, with headquarters in Belgium and North America. The company develops advanced proton therapy technologies, including the Proteus® line, which features innovations like pencil beam scanning and spot scanning proton arc therapy. IBA's systems have been installed in over 60 medical centers worldwide, treating more than 50,000 cancer patients across 21 countries. In addition to proton therapy, IBA is involved in particle accelerators for industrial sterilization and offers radiopharmaceuticals and dosimetry solutions. IBA provides services such as equipment installation, maintenance, clinical support, and training through its Proton Therapy Academy. The company emphasizes collaboration with healthcare providers to enhance treatment performance and supports the expansion of cancer care globally.

• Employees 43